A little disingenuous by HLS to throw statins in the graph. But Vascepa doing better than PCSK9. Probably cost I assume, but in reality it should be based on effectiveness. Does a patient in Canada pay the same (assuming provincial reimbursement) for PCSK9 as for Vascepa??
Market Data 
Markets 
AI
